Time to treatment with thrombolytic therapy: Determinants and effect on short-term nonfatal outcomes of acute myocardial infarction

CMAJ. Canadian Medical Association Journal

Volumn 156, Issue 4, 1997, Pages 497-505

  Cox, Jafna L ^a,b   Lee, Eileen ^a,c   Langer, Anatoly ^d,e   Armstrong, Paul W ^f   Naylor, C David ^a,c  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ASYSTOLE; CANADA; COHORT ANALYSIS; FEMALE; FIBRINOLYTIC THERAPY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; SHOCK; TREATMENT OUTCOME;

EID: 0031057071     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
2. LATE Study Group. Late assessment of thrombolytic efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993;342:759-66.
3. FTT Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
4. Lincoff AM, Topol EJ. Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993;88:1361-74.
5. The Heart and Stroke Foundation of Canada, the Canadian Cardiovascular Society and the Canadian Association of Emergency Physicians, for the Emergency Cardiac Care Coalition. Recommendations for ensuring early thrombolytic therapy for acute myocardial infarction. Can Med Assoc J 1996;154:483-7.
6. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT, et al. Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction. Circulation 1994;90:2103-14.
7. Birkhead JS on behalf of the Joint Audit Committee of the British Cardiac Society and a Cardiology Committee of the Royal College of Physicians of London. Time delays in provision of thrombolytic treatment in six district hospitals. BMJ 1992;305:445-8.
8. GISSI-Avoidable Delay Study Group. Epidemiology of avoidable delay in the care of patients with acute myocardial infarction in Italy. A GISSI-generated study. Arch Intern Med 1995;155:1481-8.
9. Porter G, Doughty R, Gamble G, Sharpe N. Thrombolysis in acute myocardial infarction: reducing in hospital treatment delay. N Z Med J 1995;108:253-4.
10. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. Circulation 1995;91:1659-68.
11. Koren G, Weiss AT, Hasin Y, Appelbaum D, Welber S, Rozenman Y, et al. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med 1985;313:1384-9.
12. Mathey DG, Sheehan FH, Schofer J, Dodge HT. Time from onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction. J Am Coll Cardiol 1985;6:518-25.
13. Simoons ML, Serruys PW, van den Brand M, Res J, Verheugt FW, Krauss XH, et al, for the Working Group on Thrombolytic Therapy in Acute Myocardial Infarction of the Netherlands Interuniversity Cardiology Institute. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cordiol 1986;7:717-28.
14. Weaver WD, Cerqueira M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, et al, for the Myocardial Infarction Triage and Intervention Project Group. Prehospital-initiated vs hospital-initiated thrombolytic therapy. JAMA 1993;270:1211-6.
15. Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ, Granger CB, et al. Use of medical resources and quality of life alter acute myocardial infarction in Canada and the United States. N Engl J Med 1994;331:1130-5.
16. Van de Werf F, Topol EJ, Lee KL, Woodlief LH, Granger CB, Armstrong PW, et al. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. JAMA 1995;273:1586-91.
17. Jha P, DeBoer D, Sykorn K, Naylor CD. Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. J Am Coll Cardiol 1996;27:1335-42.
18. Weaver WD. Time to thrombolytic treatment: factors affecting delay and their influence outcome. J Am Coll Cardiol 1995;25(suppl):3S-9S.
19. Moses HW, Bartolozzi JJ, Koester DL, Colliver JA, Taylor GJ, Mikell FL, et al. Reducing delay in the emergency room in administration of thrombolytic therapy for myocardial infarction associated with ST elevation. Am J Cardiol 1991;68:251-3.
20. Cairns J, Armstrong PW, Belenkie I, Hirsh J, Johnstone DE, Knudtson M, et al. Maximizing the benefits of thrombolytic therapy for acute myocardial infarction. Can Med Assoc J 1992;152:819-22.
21. Maggioni AP, Maseri A, Fresco C, Framosi MG, Mauri F, Santoro E, et al. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. N Engl J Med 1993;329:1442-8.
22. Naylor CD, Chen E. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: the Ontario experience, 1981 to 1991. J Am Coll Cardiol 1994;24:1431-8.
23. Gurwitz JH, Coldberg RJ, Chen Z, Gore JM, Alpert JS. Recent trends in hospital mortality of acute myocardial infarction - the Worcester Heart Attack Study. Arch Intern Med 1994;154:2202-8.
24. Tsuyuki RT, Teo KK, Ikuta RM, Bay KS, Greenwood PV, Montague PJ. Mortality risk and patterns of practice in 2,070 patients with acute myocardial infarction, 1987-1992. The relative importance of age, sex and medical therapy. Chest 1994;105:1687-92.
25. Montague TJ, Wong R, Crowell R, Bay K, Marshall D, Tymchak W, et al. Acute myocardial infarction: contemporary risk and management in older versus younger patients. Can J Cardiol 1990;6:241-6.
26. Montague TJ, Ikuta RM, Wong RY, Bay KS, Teo KK, Davies NJ. Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987-1989). Am J Cardiol 1991;68:843-7.
27. Montague TJ, Wong RY, Burton JR, Bay KS, Catellier DJ, Teo KK. Changes in acute myocardiol infarction risk and patterns of practice for patients older and younger than 20 years, 1987-1990. Can J Cardiol 1992;8:596-600.
28. Montague T, Taylor L, Barnes M, Ackman M, Tsuyuki K, et al, for the Clinical Quality Improvement Network Investigators. Can practice patterns be successfully altered? Examples from cardiovascular medicine. Can J Cardiol 1995;11:487-92.
29. Cairns J, Armstrong P, Belenkie I, Hirsh J, Johnstone D, Knudtson M, et al. Canadian Consensus Conference on Coronary Thrombolysis - 1994 update. Can J Cardiol 1994;10:517-29.